| MDL number | MFCD02259123 |
|---|---|
| UNSPSC Code | 51191904 |
| NACRES | NA.25 |
| SMILES string | [H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O |
| InChI | 1S/C41H78NO8P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-40(43)47-37-39(38-49-51(45,46)48-36-35-42)50-41(44)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h17-20,39H,3-16,21-38,42H2,1-2H3,(H,45,46)/b19-17-,20-18-/t39-/m1/s1 |
| InChI key | MWRBNPKJOOWZPW-NYVOMTAGSA-N |
| description | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine |
| assay | >99% (TLC) |
| form | powder |
| packaging | pkg of 1 × 1 g (850725P-1g) |
| manufacturer/tradename | Avanti Research™ - A Croda Brand |
| application(s) | advanced drug delivery |
| lipid type | cardiolipinsphospholipids |
| shipped in | dry ice |
| storage temp. | −20°C |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
